Top Markets
#1 0G 0G +38.62%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.25%
#3 Useless Coin Useless Coin +34.12%
#4 StonkBroker StonkBroker +31.74%
#5 Arbitrum Arbitrum +31.19%
#6 SAFEcoin SAFEcoin +28.71%
#7 Notcoin Notcoin +19.84%
#8 Pons Pons +18.99%
#9 Full Moon Full Moon +18.20%
#10 Curve DAO Curve DAO +16.10%
Coin of the day
0G 0G
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
EirGenix Inc. EirGenix Inc.

EirGenix Inc.

6589
Classement en actions #14111
EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions... EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions as a contract development and manufacturing organization (CDMO) with operations spanning both domestic and international markets. The company offers a comprehensive range of services, encompassing cell line creation, process optimization, analytical testing and quality control, and current Good Manufacturing Practice (cGMP) compliant production utilizing both mammalian and microbial expression systems. They also specialize in services related to antibody-drug conjugates (ADCs). Beyond its service offerings, EirGenix is actively engaged in developing several therapeutic candidates. This pipeline includes EG12014/EGI014, a Trastuzumab biosimilar intended for cancer therapy, which has reached the biologics license application (BLA) submission stage. Other oncology-focused developments are EG1206A, a Pertuzumab biosimilar currently in Phase I clinical trials; EG13074, in preclinical development; and TSY0110(EG12043), an antibody-drug conjugate also in preclinical stages. Additionally, the company is advancing EG12021, a Bevacizumab biosimilar for cancer treatment, and EG62054, another biosimilar, both in preclinical development. In addition to its core activities, EirGenix manufactures and distributes a rapid antigen test for COVID-19, as well as the CRM197 carrier protein under the designation EG74032.
Prix de l'action
$1.46
Dernière synchronisation: 2026-07-28
Capitalisation boursière
$435.25M
Changement (1 jour)
-2.34%
Changement (1 an)
-26.63%
Pays
TW
Échange EirGenix Inc. (6589)

Catégorie

Healthcare
Le prix 6589 avec la capitalisation boursière de B
EirGenix Inc. EirGenix Inc.
6589
$1.46
Capitalisation boursière de EirGenix Inc.(6589)
Capitalisation boursière: $435.25M
En August 2026, EirGenix Inc. a une capitalisation boursière de $435.25M. Cela fait de EirGenix Inc. la 14111th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de EirGenix Inc. du 2016 au 2026
6589 par rapport au top 5 des plus populaires stocks
Prix pour 6589 L’actif B La capitalisation boursière de B Résultats
EirGenix Inc. EirGenix Inc.
$17,882.30 $435.25M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.327T +1,223,738.36%
EirGenix Inc. EirGenix Inc.
$15,593.04 $435.25M
Apple Inc. Apple Inc.
AAPL
$4.645T +1,067,064.92%
EirGenix Inc. EirGenix Inc.
$13,664.03 $435.25M
Alphabet Inc. Alphabet Inc.
GOOG
$4.070T +935,046.33%
EirGenix Inc. EirGenix Inc.
$12,704.99 $435.25M
Microsoft Corporation Microsoft Corporation
MSFT
$3.785T +869,411.03%
EirGenix Inc. EirGenix Inc.
$9,366.56 $435.25M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.790T +640,933.47%